期刊
PEDIATRIC PULMONOLOGY
卷 58, 期 3, 页码 811-818出版社
WILEY
DOI: 10.1002/ppul.26257
关键词
acid suppressive medications; CFTR modulators; cystic fibrosis; pancreatic enzyme replacement therapy; proton pump inhibitors
This study examines the current use of acid-suppressive medications (ASM) and pancreatic enzyme therapy (PERT) in patients with CF and their interest in a standardized withdrawal study. The results show that there is interest among patients and CF providers in pursuing research on simplifying the gastrointestinal regimen for CF patients on highly effective modulator therapy (HEMT).
IntroductionThe success of highly effective modulator therapy (HEMT) has led to consideration of simpler regimens for people with CF (PwCF) with opportunities to modify burdensome regimens. Despite the intuitive appeal of discontinuing chronic therapies no longer necessary, this process should be pursued systematically to ensure safety, adherence, and validate patient-centered preferences. We designed a questionnaire to determine the state of use of acid-suppressive medications (ASM) and pancreatic enzyme therapy (PERT), current self-withdrawal and provider-directed withdrawal practices, and interest in a standardized withdrawal study. MethodsIn collaboration with CF Foundation (CFF), a questionnaire was developed and distributed to members of Community Voice (CV, comprised of PwCF and their loved ones), and CF providers regarding the need to study simplifying the gastrointestinal (GI) regimen for PwCF on HEMT. ResultsApproximately 20-40% of CV or CF providers have decreased or stopped ASM for those on HEMT. For PERT, CV and CF providers have decreased dose (34%-48% and approximately 25%, respectively) more often than having stopped it altogether (13%-24% and 3%-12%, respectively). Cumulatively, there is interest in pursuing research in this area (86% CV and 89% CF providers) and willingness to enroll in such a study (80% CV and 89% CF providers). ConclusionSystematically studying the withdrawal of common GI medications, ASM and PERT, is important to CV and CF providers. Decreases in dosing and withdrawal are already taking place without evidence to support this practice. This questionnaire is the first step in designing a GI medication simplification study in PwCF on HEMT.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据